Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Catalyst Pharmaceuticals Inc shares valued at $272,654 were sold by INGENITO GARY on Nov 27 ’24. At $22.72 per share, INGENITO GARY sold 12,000 shares. The insider’s holdings dropped to 51,391 shares worth approximately $1.12 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Harper Molly sold 17,500 shares, netting a total of over 385,000 in proceeds. Following the sale of shares at $22.00 each, the insider now holds 0 shares.
Before that, Elsbernd Brian had sold 13,256 shares from its account. In a trade valued at $286,704, the Chief Compliance/Legal Officer traded Catalyst Pharmaceuticals Inc shares for $21.63 each. Upon closing the transaction, the insider’s holdings decreased to 13,256 shares, worth approximately $3.59 million.
As published in their initiating research note from Stephens on November 18, 2024, Catalyst Pharmaceuticals Inc [CPRX] has been an Overweight and the price target has been revised to $35. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of March 07, 2024, BofA Securities has initiated its “Buy” rating for CPRX. Earlier on December 21, 2023, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for CPRX stock.
Analyzing CPRX Stock Performance
During the last five days, there has been a drop of approximately -2.86%. Over the course of the year, Catalyst Pharmaceuticals Inc shares have jumped approximately 29.09%. Shares of the company reached a 52-week high of $24.27 on 11/08/24 and a 52-week low of $13.12 on 02/08/24. A 50-day SMA is recorded $21.35, while a 200-day SMA reached $17.94. Nevertheless, trading volume fell to 0.68 million shares from 0.88 million shares the previous day.
Support And Resistance Levels for Catalyst Pharmaceuticals Inc (CPRX)
According to the 24-hour chart, there is a support level at 21.49, which, if violated, would cause prices to drop to 21.29. In the upper region, resistance lies at 21.91. The next price resistance is at 22.13. RSI (Relative Strength Index) is 49.59 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.22, which suggests the price will decrease in the coming days. Percent R is at 51.16%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
